Rayeheh Tavajohi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Rayeheh Tavajohi has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Abdorreza Naser Moghadasi
Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication- Abdorreza Naser Moghadasi
Multiple Sclerosis Research Center, Neuroscience Institute Tehran University of Medical Sciences Tehran Iran
1 shared publication - Amirreza Azimi
Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication - Amitis Sarbaz
Georgia School of Orthodontics Atlanta Georgia USA
1 shared publication - Bita Shahrami
Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication Hooshyar Honarmand
Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Research Center for Rational Use of Drugs, Tehran University of Medical Sciences, Tehran, Iran; Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by Wiley in European Journal of Cancer Care
- Vol. 2025 (1)
The Role of Antioxidant Supplementation in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Review
Background: Patients undergoing hematopoietic stem cell transplantation (HSCT) often face complications during the acute posttransplantation period. HSCT complications are linked to oxidative stress (OS) mechanisms due to accumulation of reactive oxygen species. Researchers hypothesize that antioxidant levels may modify OS immediately after HSCT. Objective: This systematic review aimed to collect evidence on the role of antioxidant supplementation in determining the outcomes and complications of HSCT. Study Design: A systematic search of two databases was conducted, including studies published until January 2024. Inclusion criteria involved clinical original studies focusing on adults and children undergoing HSCT who received antioxidant supplementation during and/or after HSCT. Results: The review included 20 eligible studies, featuring antioxidants such as N‐acetyl cysteine, vitamin C, zinc, selenium, vitamin E, and melatonin. Outcomes examined included immune system recovery, engraftment, oral mucositis, liver toxicity, nephrotoxicity, and acute graft‐versus‐host disease. The findings indicate an unclear association between antioxidant use and complications after HSCT. The certainty of evidence for these outcomes was low or very low. Conclusions: Although the use of antioxidants in HSCT patients has been deemed safe and has even been associated with positive outcomes in some studies, the necessity for antioxidant supplementation during HSCT remains uncertain. Further large randomized controlled trials are necessary to ascertain antioxidant requirements and establish precise supplementation protocols for HSCT patients.
- 1 January 2025
- Published by Wiley in European Journal of Cancer Care
- Vol. 2025 (1)
Open AccessThe Role of Antioxidant Supplementation in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Review
Background: Patients undergoing hematopoietic stem cell transplantation (HSCT) often face complications during the acute posttransplantation period. HSCT complications are linked to oxidative stress (OS) mechanisms due to accumulation of reactive oxygen species. Researchers hypothesize that antioxidant levels may modify OS immediately after HSCT. Objective: This systematic review aimed to collect evidence on the role of antioxidant supplementation in determining the outcomes and complications of HSCT. Study Design: A systematic search of two databases was conducted, including studies published until January 2024. Inclusion criteria involved clinical original studies focusing on adults and children undergoing HSCT who received antioxidant supplementation during and/or after HSCT. Results: The review included 20 eligible studies, featuring antioxidants such as N‐acetyl cysteine, vitamin C, zinc, selenium, vitamin E, and melatonin. Outcomes examined included immune system recovery, engraftment, oral mucositis, liver toxicity, nephrotoxicity, and acute graft‐versus‐host disease. The findings indicate an unclear association between antioxidant use and complications after HSCT. The certainty of evidence for these outcomes was low or very low. Conclusions: Although the use of antioxidants in HSCT patients has been deemed safe and has even been associated with positive outcomes in some studies, the necessity for antioxidant supplementation during HSCT remains uncertain. Further large randomized controlled trials are necessary to ascertain antioxidant requirements and establish precise supplementation protocols for HSCT patients.
- Open Access
- 6 August 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (8) , e9261
Chronic periodontitis in a patient with multiple sclerosis—A case report
Key Clinical Message: Multiple sclerosis (MS) is one of the common central nervous system diseases, but it can cause dysfunction in other organs such as periodontal tissues. However, it has not been as noticeable. This report aimed to present a 44‐year‐old patient with severe chronic periodontitis, and sudden teeth loss since the diagnosis of MS.
- 6 August 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (8) , e9261
Open AccessChronic periodontitis in a patient with multiple sclerosis—A case report
Key Clinical Message: Multiple sclerosis (MS) is one of the common central nervous system diseases, but it can cause dysfunction in other organs such as periodontal tissues. However, it has not been as noticeable. This report aimed to present a 44‐year‐old patient with severe chronic periodontitis, and sudden teeth loss since the diagnosis of MS.